Heuckmann, Johannes M <br/><br/>
ALK mutations conferring differential resistance to structurally diverse ALK inhibitors.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Dec 2011 
 - 7394-401 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-11-1648  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anaplastic Lymphoma Kinase<br/>Antineoplastic Agents--pharmacology<br/>Cell Cycle Proteins--genetics<br/>Cell Line, Tumor<br/>Crizotinib<br/>Drug Resistance, Neoplasm--genetics<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Microtubule-Associated Proteins--genetics<br/>Mutation<br/>Neuroblastoma--drug therapy<br/>Oncogene Proteins, Fusion--genetics<br/>Polymorphism, Single Nucleotide<br/>Pyrazoles--pharmacology<br/>Pyridines--pharmacology<br/>Pyrimidines--pharmacology<br/>Receptor Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Serine Endopeptidases--genetics